Saliva has gained attention as a diagnostic fluid: salivary biomarkers such as lactotransferrin, multi-omics signatures, and oral microbial profiles have been associated with AD risk and progression [24,25,26]. This evidence concerns the gene LTF and Alzheimer disease.